ROSG has found resistance at the $4.00 mark multiple times in recent days. With a combination of consolidation and the narrowing of support -- ROSG is poised to make a breakout to either the upside or downside. Based on a support from $3.88 to $3.92 and an upside potential of ~$4.20, there is a larger upside than downside. Additionally this company has 2 new bladder cancer assays being commercially introduced during the American Urological Association's (AUA) annual meeting running from May 15th to May 19th; suggesting that news will be released soon about how the products faired during the meeting.
Note that buying any stock carries with it uncertainty. Buy at your own risk.
Note that buying any stock carries with it uncertainty. Buy at your own risk.